Electronic-cigarette or vaping use-associated lung injury (EVALI) is a serious health concern, especially among adolescents. During the COVID-19 pandemic, distinguishing EVALI from COVID-19 has posed diagnostic challenges for healthcare providers.
This article reviews a series of cases from a large children's hospital to shed light on the clinical features and importance of accurate diagnosis for effective management.